-+ 0.00%
-+ 0.00%
-+ 0.00%

4D Molecular Therapeutics CEO David Kirn disposes of 58,333 common shares worth $810,105.1

PUBT·09/16/2026 21:14:42
Listen to the news
4D Molecular Therapeutics CEO David Kirn disposes of 58,333 common shares worth $810,105.1
  • David Kirn, president, CEO, sold 58,333 shares of 4D Molecular Therapeutics common stock on Sept. 14, 2026.
  • Sale priced at USD 13.9 per share, based on a weighted average.
  • Post-transaction beneficial ownership totaled 767,486 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-393243), on September 16, 2026, and is solely responsible for the information contained therein.